Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
CTEP is the first reported mGlu5 inhibitor with both long half-life of approximately 18 h and high oral bioavailability allowing chronic treatment with continuous receptor blockade with one dose every 48 h in adult and newborn animals
which was demonstrated by that extraordinary selectivity ratios of 17600
CAS Number: 16564-43-5
CAS Number: 109-52-4
Metaproterenol hemisulfate also has anti-inflammatory activity
Eleutheroside E adine hydrochloride CTEP is the first reportedEleutheroside E, a principal component of Eleutherococcus enticosus, has anti inflammatory and protective effects in ischemia heart. IC50 value: Target: In vitro: Treatment of 10 M Eleutheroside E (EE) for 24 h increased basal glucose uptake as well as improved TNF mediated suppression of glucose uptake. In vivo: To investigate the effect of Eleutheroside E (EE) on arthritis, the CIA model in DBA 1 mice was used. Compared to vehicle treated CIA mice,
US$ 599.50
US$ 949.50
US$ 12.99
US$ 1149.50
US$ 649.50
US$ 649.50
US$ 1249.50
US$ 474.50
US$ 499.50
US$ 499.50